Pandemic Immunoprivilege

As COVID-19 vaccines open up for all adults in the United States, Maria and Julio unpack the next phase of the pandemic and its global impact, including vaccination equity and immunoprivilege. For this discussion, they’re joined by Dr. Keisha Ray, bioethicist at McGovern Medical School at University of Texas Health in Houston, and Dr. Peter Hotez, co-director of the Texas Children's Center for Vaccine Development and dean of the National School of Tropical Medicine. Also ITT familia! In The Thick is nominated for the Best General Series in News and Politics category in the 25th Annual Webby Awards! Vote for us here. And help spread the word by sharing on social media. ITT Staff Picks: - In an interview for Vox with Sigal Samuel, Kesiha spoke about vaccine hesitancy among communities of color: “It’s not that people of color just don’t trust medicine. It’s that medicine hasn’t shown itself to be trustworthy to people of color.” - Debora Dinz and Giselle Carino write about the geopolitics of immunoprivilege for El Pais’ Opinion section. - Ranna Ayyub writes for Time Magazine about the COVID-19 crisis in India and the Prime Minister’s failure to lead during this second wave. Photo credit: AP Photo / Carlos Giusti See acast.com/privacy for privacy and opt-out information. Want to support our independent journalism? Join Futuro+ for ad-free listening, early-access and exclusive bonus episodes with the chisme behind In The Thick and all our podcasts: www.futuromediagroup.org/joinplus. Hosted on Acast. See acast.com/privacy for more information.